Clinical Trial Update: A Phase II, Single-arm, Multicenter, Prospective Study of Cardunolizumab in Recurrent or Metastatic Vulvar and Vaginal Cancer [Phase 2]

View source ↗

Summary

A Phase II, single-arm, multicenter prospective study of Cardunolizumab in recurrent or metastatic vulvar and vaginal cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vaginal Cancer
• Vulvar Cancer

Drugs mentioned

• Cardunolizumab

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Vulvar and Vaginal Cancer | Phase 2 | Status: RECRUITING